Furthermore, elevated plasma GFAP levels were significantly associated with faster cognitive decline among APOE ε4 carriers, suggesting a high vulnerability of astrocytosis and neuroinflammation in genetically high-risk groups [214]. This evidence concerns the gene GFAP and Mental deterioration.